Bain Capital Life Sciences Maintains Significant Stake in Pharvaris N.V.

Ticker: PHVS · Form: SC 13G/A · Filed: 2024-01-22T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, pharmaceuticals, investor-update

TL;DR

**Bain Capital still holds a big chunk of Pharvaris, signaling confidence.**

AI Summary

Bain Capital Life Sciences Fund, L.P. filed an amended SC 13G/A on January 22, 2024, indicating their continued significant ownership in Pharvaris N.V. The filing, triggered by an event on January 18, 2024, updates their beneficial ownership of Pharvaris's Ordinary Shares, par value €0.12 per share. This matters to investors because Bain Capital is a major institutional holder, and their continued stake signals confidence in the pharmaceutical company's future, potentially influencing stock stability and investor sentiment.

Why It Matters

Bain Capital's sustained investment suggests a positive long-term outlook for Pharvaris N.V., which could reassure current and prospective shareholders about the company's prospects.

Risk Assessment

Risk Level: low — This filing is an update to an existing ownership stake, not a new acquisition or divestiture, indicating stability rather than immediate risk.

Analyst Insight

Investors should view this filing as a confirmation of existing institutional ownership rather than a new catalyst. It reinforces the stability of a major investor's position, which can be a positive signal, but doesn't suggest immediate price movement. Further research into Pharvaris N.V.'s fundamentals and pipeline is warranted.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What type of shares of Pharvaris N.V. does Bain Capital Life Sciences Fund, L.P. beneficially own?

Bain Capital Life Sciences Fund, L.P. beneficially owns "Ordinary Shares, €0.12 par value per share" of Pharvaris N.V., as stated in the filing under 'Title of Class of Securities'.

What was the specific date that triggered the requirement for this SC 13G/A amendment?

The 'Date of Event Which Requires Filing of This Statement' was January 18, 2024, according to the filing.

Which rule under the Securities Exchange Act of 1934 is this Schedule 13G filed under?

This Schedule 13G is filed under Rule 13d-1(c), as indicated by the checked box '☒ Rule 13d-1(c)' on the cover page.

What is the CUSIP Number for Pharvaris N.V.'s Ordinary Shares?

The CUSIP Number for Pharvaris N.V.'s Ordinary Shares is N69605108, as listed in the filing.

Where is the business address for Bain Capital Life Sciences Fund, L.P.?

The business address for Bain Capital Life Sciences Fund, L.P. is 200 Clarendon Street, Boston, MA 02116, as detailed in the 'FILED BY' section of the filing.

From the Filing

0001193125-24-012198.txt : 20240122 0001193125-24-012198.hdr.sgml : 20240122 20240122163025 ACCESSION NUMBER: 0001193125-24-012198 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240122 DATE AS OF CHANGE: 20240122 GROUP MEMBERS: BAIN CAPITAL LIFE SCIENCES OPPORTUNITIES III, LP GROUP MEMBERS: BCIP LIFE SCIENCES ASSOCIATES, LP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92181 FILM NUMBER: 24549190 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Bain Capital Life Sciences Fund, L.P. CENTRAL INDEX KEY: 0001687968 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-516-2000 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 SC 13G/A 1 d737649dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 2) PHARVARIS N.V. (Name of Issuer) Ordinary Shares, €0.12 par value per share (Title of Class of Securities) N69605108 (CUSIP Number) January 18, 2024 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”), or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. N69605108 13G Page 2 of 8 Pages 1 Names of Reporting Persons Bain Capital Life Sciences Fund, L.P. 2 Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☐ 3 SEC Use Only 4 Citizenship or Place of Organization Cayman Islands Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 Ordinary Shares 6 Shared Voting Power 1,967,093 Ordinary Shares 7 Sole Dispositive Power 0 Ordinary Shares 8 Shared Dispositive Power 1,967,093 Ordinary Shares 9 Aggregate Amount Beneficially Owned by Each Reporting Person 1,967,093 Ordinary Shares 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares ☐ 11 Percent of Class Represented by Amount in Row 9 3.8% 12 Type of Reporting Person PN CUSIP No. N69605108 13G Page 3 of 8 Pages 1 Names of Reporting Persons BCIP Life Sciences Associates, LP 2 Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☐ 3 SEC Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 Ordinary Shares 6 Shared Voting Power 201,347 Ordinary Shares 7

View on Read The Filing